as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
3.34%
Downside
0.22%
Upside
52 Week's Low
52 Week's High
14.89%
Downside
64.73%
Upside
Check Conmed Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.2B
EPS (TTM)
4.5009
Dividend Yield
1.08%
Quarterly Earnings Growth YOY
-0.50%
PE Ratio (TTM)
19.99
Industry PE ratio
5.383461538461538
PEG Ratio
5.29
EBITDA
264.1M
Revenue (TTM)
1.4B
Profit Margin
4.76%
Return On Equity TTM
6.60%
Track how Conmed Corp P/E has moved over time to understand its valuation trends.
Conmed Corp in the last 5 years
Lowest (10.48x)
December 31, 2025
Industry (5.38x)
February 7, 2026
Today (19.99x)
February 7, 2026
Highest (45.55x)
June 30, 2023
Today’s Price to Earnings Ratio: 19.99x
Compare market cap, revenue, PE, and other key metrics of Conmed Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.2B | NA | 19.99 | 4.76% | |
| BUY | $138.7B | 95.76% | 50.03 | 14.43% | |
| BUY | $136.5B | 50.05% | 46.97 | 12.07% | |
| BUY | $129.1B | -13.09% | 27.28 | 13.71% | |
| BUY | $189.3B | -10.64% | 29.24 | 14.72% |
The Conmed Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Conmed Corp investment value today
Current value as on today
₹66,075
Returns
Returns from Conmed Corp Stock
Dollar Returns*
₹3,513 (+3.51%)
Based on 14 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Conmed Corp. Average target price of $47.4
Get share price movements and forecasts by analysts on Conmed Corp.
What analysts predicted
12.32%UPSIDE
Target Price
$47.4
Current Price
$41.56
Analyzed by
14 Analysts
Target
$47.40
Conmed Corp target price $47.4, a slight upside of 12.32% compared to current price of $41.56. According to 14 analysts rating.
Search interest for Conmed Corp Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:53% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 337.92M → 373.19M (in $), with an average increase of 9.5% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 2.85M → 16.73M (in $), with an average increase of 82.9% per quarter
Price Rise
![]()
In the last 7 days, CNMD stock has moved up by 8.2%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 18.8% return, outperforming this stock by 79.5%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 14.3% return, outperforming this stock by 51.8%
| Organisation | Conmed Corp |
| Headquarters | 11311 Concept Boulevard, Largo, FL, United States, 33773-4908 |
| Industry | Health Technology |
| CEO | Mr. Patrick J. Beyer |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Todd W. Garner CPA | Executive VP of Finance & CFO |
Mr. Curt R. Hartman | Special Advisor |
Mr. Richard Glaze | Chief Information Officer |
Ms. Hollie K. Foust | Executive VP, General Counsel & Corporate Secretary |
Ms. Shanna L. Cotti-Osmanski | Executive VP of Information Technology & CIO |
Mr. Patrick J. Beyer | President, CEO & Director |
Mr. Brent Lalomia | Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, & Commercial Operations |
Mr. Andrew Moller | Principal Accounting Officer, VP & Corporate Controller |
Mr. John Ferrell | Executive Vice President of Human Resources |
Mr. Peter K. Shagory | Executive Vice President of Strategy & Corporate Development |
Conmed Corp share price today is $41.56 as on at the close of the market. Conmed Corp share today touched a day high of $41.65 and a low of $40.17.
Conmed Corp share touched a 52 week high of $68.46 on and a 52 week low of $35.37 on . Conmed Corp stock price today i.e. is closed at $41.56,which is 39.29% down from its 52 week high and 17.50% up from its 52 week low.
Conmed Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Conmed Corp (CNMD) shares with as little as ₹90.662 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.62 in Conmed Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Conmed Corp share’s latest price of $41.56 as on February 7, 2026 at 2:29 am IST, you will get 0.2406 shares of Conmed Corp. Learn more about
fractional shares .